Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Meta-analysis should not have included one of the studies
| The first 150 words of the full text of this article appear below. |
EDITOR
Several points relating to Knoll and Bell's meta-analysis of
randomised trials comparing cyclosporin (Sandimmun) and tacrolimus may
have a bearing on its conclusions.1 Unfortunately, the
first study cited
that by Shapiro et al
does not have a minimum of
one year's follow up; the "median follow-up is 1.12 years, with a
range of 0.17 to 2.25 years."2 This trial by Shapiro et
al should also be excluded on the grounds that it is not a randomised
trial but compares a group of patients treated with tacrolimus with
"a nearly concurrent group of patients treated with cyclosporine."
Drawing conclusions is also difficult because two of the studies
routinely used antibody induction therapy and a third study did not
detail whether it did or not. This is a practice not commonly adopted
in the United Kingdom. Furthermore, the drug doses, routes of
administration, drug monitoring, and treatment of rejection episodes
differed considerably between